SCHEMBL17845355

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL31122037	1.00	PARG (0.57)	PARGGRIN1GRIN2BBRD4ALDH1A1
	SCHEMBL31121949	0.80	PARG (0.53)	PARGPIK3CAPRKDC
	SCHEMBL17845419	0.80	PARG (0.53)	PARGPIK3CAPRKDC
	SCHEMBL17845620	0.74	PARG (0.60)	PARG
	SCHEMBL31122041	0.73	PARG (1.00)	PARG
	SCHEMBL17845429	0.73	PARG (1.00)	PARG
	SCHEMBL17863699	0.65	PARG (0.52)	PARG
	SCHEMBL31121965	0.65	PARG (0.52)	PARG
	SCHEMBL20206661	0.65	TDP1 (0.48)	GRIN1GRIN2BBRD4ALDH1A1PTGER4
	SCHEMBL17845479	0.64	GRIN1 (0.55)	GRIN1GRIN2BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.